Janice McCourt - Nov 8, 2022 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role
Chief Business Officer
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Stock symbol
CMRA
Transactions as of
Nov 8, 2022
Transactions value $
$0
Form type
4
Date filed
11/9/2022, 03:19 PM
Previous filing
Nov 9, 2022
Next filing
Oct 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Stock Option (Right to Purchase) Award $0 +150K $0.00 150K Nov 8, 2022 Common Stock 150K $1.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on November 1, 2023 and the remainder vesting in equal monthly installments thereafter.